ATE262525T1 - Indolderivate zur verwendung in der behandlung von zns-störungen - Google Patents

Indolderivate zur verwendung in der behandlung von zns-störungen

Info

Publication number: ATE262525T1
Authority: AT; Austria
Prior art keywords: treatment; cns disorders; indole derivatives; indole; derivatives
Prior art date: 2000-06-19

Application number

AT01940242T

Other languages

English (en)

Inventor

Benny Bang-Andersen

Krestian Larsen

Jan Kehler

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-19

Filing date

2001-06-13

Publication date

2004-04-15

2001-06-13 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2004-04-15 Application granted granted Critical

2004-04-15 Publication of ATE262525T1 publication Critical patent/ATE262525T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AT01940242T 2000-06-19 2001-06-13 Indolderivate zur verwendung in der behandlung von zns-störungen ATE262525T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DKPA200000957		2000-06-19
US21253200P	2000-06-20	2000-06-20
PCT/DK2001/000408 WO2001098298A1 (en)	2000-06-19	2001-06-13	Indole derivatives useful for the treatment of cns disorders

Publications (1)

Publication Number	Publication Date
ATE262525T1 true ATE262525T1 (de)	2004-04-15

Family

ID=26068837

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01940242T ATE262525T1 (de)	2000-06-19	2001-06-13	Indolderivate zur verwendung in der behandlung von zns-störungen

Country Status (14)

Country	Link
EP (1)	EP1299384B1 (de)
JP (1)	JP2004501151A (de)
KR (1)	KR20030007975A (de)
CN (1)	CN1446216A (de)
AR (1)	AR028945A1 (de)
AT (1)	ATE262525T1 (de)
AU (1)	AU2001273883A1 (de)
CA (1)	CA2412141A1 (de)
CZ (1)	CZ200357A3 (de)
DE (1)	DE60102471T2 (de)
HU (1)	HUP0301748A2 (de)
MX (1)	MXPA02012568A (de)
NO (1)	NO20026028D0 (de)
WO (1)	WO2001098298A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7855195B2 (en)	2003-12-02	2010-12-21	Pharmaneuroboost N.V.	Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP1547650A1 (de) *	2003-12-02	2005-06-29	B & B Beheer NV	Verwendung von D4 und 5-HT2A Antagonisten, inverse Agonisten order partielle Agonisten
EP2272514A1 (de)	2003-12-02	2011-01-12	PharmaNeuroBoost N.V.	Verwendung von niedrigdosiertem Pipamperon und einem zweiten Wirkstoff zur Behandlung von neurodegenerativen Erkrankungen
US7884096B2 (en)	2003-12-02	2011-02-08	Pharmaneuroboost N.V.	Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL310443A1 (en) *	1993-03-01	1995-12-11	Merck Sharp & Dohme	Derivatives of pyrolo-pyridine
DE19500689A1 (de) *	1995-01-12	1996-07-18	Merck Patent Gmbh	Indolpiperidin-Derivate
GB9700895D0 (en) *	1997-01-17	1997-03-05	Lilly Co Eli	Pharmaceutical compounds

2001
- 2001-06-06 AR ARP010102698A patent/AR028945A1/es unknown
- 2001-06-13 CZ CZ200357A patent/CZ200357A3/cs unknown
- 2001-06-13 AT AT01940242T patent/ATE262525T1/de not_active IP Right Cessation
- 2001-06-13 WO PCT/DK2001/000408 patent/WO2001098298A1/en not_active Application Discontinuation
- 2001-06-13 HU HU0301748A patent/HUP0301748A2/hu unknown
- 2001-06-13 JP JP2002504254A patent/JP2004501151A/ja not_active Withdrawn
- 2001-06-13 CA CA002412141A patent/CA2412141A1/en not_active Abandoned
- 2001-06-13 KR KR1020027017218A patent/KR20030007975A/ko not_active Application Discontinuation
- 2001-06-13 MX MXPA02012568A patent/MXPA02012568A/es not_active Application Discontinuation
- 2001-06-13 EP EP01940242A patent/EP1299384B1/de not_active Expired - Lifetime
- 2001-06-13 CN CN01814123A patent/CN1446216A/zh active Pending
- 2001-06-13 DE DE60102471T patent/DE60102471T2/de not_active Expired - Fee Related
- 2001-06-13 AU AU2001273883A patent/AU2001273883A1/en not_active Abandoned
2002
- 2002-12-16 NO NO20026028A patent/NO20026028D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2001098298A1 (en)	2001-12-27
MXPA02012568A (es)	2003-04-10
EP1299384A1 (de)	2003-04-09
AU2001273883A1 (en)	2002-01-02
JP2004501151A (ja)	2004-01-15
NO20026028L (no)	2002-12-16
KR20030007975A (ko)	2003-01-23
DE60102471T2 (de)	2005-02-24
CZ200357A3 (cs)	2003-04-16
EP1299384B1 (de)	2004-03-24
HUP0301748A2 (hu)	2003-09-29
AR028945A1 (es)	2003-05-28
CN1446216A (zh)	2003-10-01
NO20026028D0 (no)	2002-12-16
DE60102471D1 (de)	2004-04-29
CA2412141A1 (en)	2001-12-27

Publication	Publication Date	Title
DE60019556D1 (de)	2005-05-25	2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69936335D1 (de)	2007-08-02	Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
DE60124302D1 (de)	2006-12-14	Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE69925571D1 (de)	2005-07-07	Sulphonamid-derivate zur behandlung von störungen des zentralnervensystems
DE60019555D1 (de)	2005-05-25	2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60022867D1 (de)	2006-02-09	1-Arenesulfonyl-2-Aryl-Pyrrolidin und Piperidin Derivative zur Behandlung von CNS-Erkrankungen
DE60136477D1 (de)	2008-12-18	Retinoide zur behandlung von emphysem
DE60111379D1 (de)	2005-07-14	Indolderivate zum gebrauch in der behandlung von zns-störungen
DE60117122D1 (de)	2006-04-20	Verwendung von mirtazapin zur behandlung von schlafstörungen
ATE230741T1 (de)	2003-01-15	3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
ATE262525T1 (de)	2004-04-15	Indolderivate zur verwendung in der behandlung von zns-störungen
DE60217653D1 (de)	2007-03-08	Verwendung von melatonin zur behandlung der mit konzentrationsschwäche einhergehenden hyperaktivität
DE60103761D1 (de)	2004-07-15	Indolderivate zum gebrauch in der behandlung von zns-störungen
DE69918541D1 (de)	2004-08-12	Verwendung von nmda antagonisten zur behandlung des reizkolons
NO20030127L (no)	2003-01-10	Indolderivater nyttige for behandling av CNS-forstyrrelser
DE60005685D1 (de)	2003-11-06	Oxazinocarbazole zur behandlung von cns-erkrankungen
ATE300531T1 (de)	2005-08-15	Isonipecotamide zur behandlung von integrin vermittelten störungen
ATE345818T1 (de)	2006-12-15	S-methyl-dihydro-ziprasidone zur behandlung von psychiatrischen störungen.
DE59904564D1 (de)	2003-04-17	Verwendung von acetylcholinesterase-inhibitoren zur behandlung von delirien
DE60124373D1 (de)	2006-12-21	Verwendung von enoxaparin zur behandlung der zerebralen ischämie
HK1059086A1 (en)	2004-06-18	Indole derivatives useful for the treatment of cns disorders
IL153351A0 (en)	2003-07-06	Indole derivatives useful for the treatment of cns disorders
SI1294710T1 (en)	2005-10-31	Indole derivatives useful for the treatment of cns disorders

Legal Events

Date	Code	Title	Description
2004-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties